4.8 Article

Pseudo-single domain colloidal superparamagnetic nanoparticles designed at a physiologically tolerable AC magnetic field for clinically safe hyperthermia

期刊

NANOSCALE
卷 13, 期 46, 页码 19484-19492

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1nr04605e

关键词

-

资金

  1. Neo-Nanomedics Co. Ltd, Korea (Seoul, Republic of Korea) [1550LA03, 1550LA04, AURI-34154:Neonano 18-5]
  2. College of Engineering and Computing, and the Department of Electrical Engineering in the University of South Carolina

向作者/读者索取更多资源

In magnetic nanofluid hyperthermia, the use of pseudo-single domain-SPNP can significantly enhance the intrinsic loss power, making it a promising agent for clinically safe treatment.
Magnetic nanofluid hyperthermia (MNFH) with pure superparamagnetic nanoparticles (P-SPNPs) has drawn a huge attraction for cancer treatment modality. However, the low intrinsic loss power (ILP) and attributable degraded-biocompatibility resulting from the use of a heavy dose of P-SPNP agents as well as low heat induction efficiency in biologically safe AC magnetic field (H-AC,H-safe) are challenging for clinical applications. Here, we report an innovatively designed pseudo-single domain-SPNP (PSD-SPNP), which has the same translational advantages as that of conventional P-SPNPs but generates significantly enhanced ILP at H-AC,H-safe. According to the analyzed results, the optimized effective relaxation time, tau(eff), and magnetic out-of-phase susceptibility, chi '', precisely determined by the particle size at the specific frequency of H-AC,H-safe are the main reasons for the significantly enhanced ILP. Additionally, in vivo MNFH studies with colloidal PSD-SPNPs strongly demonstrated that it can be a promising agent for clinically safe MNFH application with high efficacy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据